Heart disease characterization and myocardial strain analysis in patients with PACS1 Neurodevelopmental Disorder

Latorre-Pellicer, Ana (Universidad de Zaragoza) ; Trujillano, Laura ; del Rincón, Julia ; Peña-Marco, Mónica ; Gil-Salvador, Marta (Universidad de Zaragoza) ; Lucia-Campos, Cristina ; Arnedo, María (Universidad de Zaragoza) ; Puisac, Beatriz (Universidad de Zaragoza) ; Ramos, Feliciano J. (Universidad de Zaragoza) ; Ayerza-Casas, Ariadna (Universidad de Zaragoza) ; Pié, Juan (Universidad de Zaragoza)

Resumen: Background: PACS1 neurodevelopmental disorder (PACS1-NDD) (MIM# 615009) is a rare autosomal dominant disease characterized by neurodevelopmental delay, dysmorphic facial features, and congenital malformations. Heart disease (HD) is frequently present in individuals with PACS1-NDD, but a compressive review of these anomalies and an evaluation of cardiac function in a cohort of patients are lacking.
Methods: (i) Cardiac evaluation in 11 PACS1-NDD patients was conducted using conventional echocardiography. (ii) Heart function was assessed by tissue Doppler imaging, and two-dimensional speckle tracking was performed in seven patients and matched controls. (iii) This systematic review focused on determining HD prevalence in individuals with PACS1-NDD.
Results: In our cohort, 7 of 11 patients presented HD. (Among them, three cases of ascending aortic dilatation (AAD) were detected and one mitral valve prolapse (MVP).) None of the patients showed echocardiographic pathological values, and the left global longitudinal strain was not significantly different between patients and controls (patients −24.26 ± 5.89% vs. controls −20.19 ± 1.75%, p = 0.3176). In the literature review, almost 42% (42/100) of individuals with PACS1-NDD reportedly experienced HD. Septal defects were the most common malformation, followed by patent ductus arteriosus.
Conclusions: Our results show a high prevalence of HD in PACS1-NDD patients; in this way, AAD and MVP are reported for the first time in this syndrome. Furthermore, a detailed cardiac function evaluation in our cohort did not reveal evidence of cardiac dysfunction in individuals with PACS1-NDD. Cardiology evaluation should be included for all individuals with Schuurs-Hoeijmakers syndrome.

Idioma: Inglés

DOI: 10.3390/jcm12124052

Año: 2023

Publicado en: Journal of Clinical Medicine 12, 12 (2023), 4052 [10 pp.]
ISSN: 2077-0383

Factor impacto JCR: 3.0 (2023)

Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 59 / 329 = 0.179 (2023) - Q1 - T1

Factor impacto CITESCORE: 5.7 - Medicine (all) (Q1)

Factor impacto SCIMAGO: 0.882 - Medicine (miscellaneous) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/DGA/B32-17R
Financiación: info:eu-repo/grantAgreement/ES/DGA/B32-20R
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/CP22-00105
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FI20-00290
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI19-01860

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Fisiología (Dpto. Farmac.Fisiol.y Med.L.F.)
Área (Departamento): Área Pediatría (Dpto. Microb.Ped.Radio.Sal.Pú.)